Cohort studyindependent cross-checkfull text checked★ key study I-ABX-07 in-depth review
Faster antibiotics in sepsis save lives
Time to Treatment and Mortality during Mandated Emergency Care for Sepsis.
Overview
Seymour CW et al.. N Engl J Med 2017 · PMID 28528569 · DOI 10.1056/NEJMoa1703058
Each hour of delay in antibiotics was linked to about 4% higher odds of death.
Does the study support the specific claim? No · Methodological quality: high
Plain-language summary
Study explained simply
- What did the researchers want to find out?
Assess timing.
- How was the study done?
Cohort.
- How many people, animals or samples were studied?
49,331 sepsis patients in 149 New York hospitals (2014-2016).
- What was actually found?
Each hour of delay to antibiotics was linked to 4% higher odds of dying in hospital; delay from 1 to 6 hours to complete the bundle meant about 3 percentage points more deaths. Faster IV fluids showed no clear effect.
- How large was the observed effect?
OR 1.04 per hour.
- What do the results mean in everyday life?
Antibiotics are vital in sepsis.
- What are the study's limitations?
Observational; antibiotic appropriateness unknown; one US state.
- What does it say about Elawady's specific claim?
Contradicts 'never antibiotics'.
- Do the results apply to Germany and Europe?
High.
- What can explicitly not be concluded from this study?
Exact causal size of benefit per hour; applies to sepsis, not to minor infections.
Scientific in-depth review
1. Full reference
- Authors
- Seymour CW et al.
- Journal
- N Engl J Med
- Year
- 2017
- Identifier
- PMID 28528569 DOI 10.1056/NEJMoa1703058
- Verification
- verified – PubMed efetch 2026-10-25
- Retracted
- no
- Corrections
- none
- Extent checked
- full text
- Conflicts of interest and funding
Supported by NIH grants R35GM119519 and K08 GM115859, VA HSR&D grant 11-109 13-079, and IPRO; author disclosure forms at NEJM.org (not in text).
2. Research question
Is faster sepsis treatment associated with lower mortality?
3. Study design and population
- Study design
- Cohort study – Retrospective observational cohort of state-mandated sepsis protocols (New York State Department of Health database), multilevel risk-adjusted logistic models
- Population
Adults (>17 years) with severe sepsis or septic shock (Sepsis-2 criteria) and sepsis protocol initiated in the emergency department within 6 h of arrival, in 149 New York hospitals (median age 73)
- Country
USA (New York)
- Period
1 April 2014 to 30 June 2016
- Sample size
49,331 patients at 149 hospitals (from 111,816 at 185 hospitals); 26,978 in fluid-bolus analysis
- Inclusion and exclusion criteria
Included: protocol initiated in ED within 6 h; 3-hour bundle completed within 12 h. Excluded: ineligible (18.8%), protocol outside ED (29.2%), after 6 h (3.3%), bundle >12 h (4.6%), contraindication, treatment-limiting advance directives, refusal, trial enrolment; hospitals with <50 cases
4. Methods and endpoints
- Exposure / intervention
Time (hours) from protocol initiation to completion of 3-hour bundle (blood culture, broad-spectrum antibiotics, lactate), to antibiotic administration, and to completion of 30 ml/kg fluid bolus
- Comparator
Per-hour delay; completion within 3 h vs 3-12 h
- Endpoints
Risk-adjusted in-hospital mortality
- Statistical methods
Multilevel logistic regression with hospital random effects, a-priori covariates (demographics, comorbidities, infection site, admission source, shock, lactate, platelets, ventilation); internally validated risk model; sensitivity analyses; quantitative bias analysis for unmeasured confounding
5. Actual results
- Results
82.5% had bundle completed within 3 h; median times: bundle 1.30 h (IQR 0.65-2.35), antibiotics 0.95 h (0.35-1.95), fluid bolus 2.56 h (1.33-4.20). In-hospital mortality 22.8% overall. Per hour to bundle completion OR 1.04 (95% CI 1.02-1.05); bundle in 3-12 h vs <=3 h OR 1.14 (1.07-1.21). Per hour to antibiotics OR 1.04 (1.03-1.06); antibiotics in 3-12 h vs <=3 h OR 1.14 (1.06-1.22). Associations stronger in patients receiving vasopressors. Fluid bolus per hour OR 1.01 (0.99-1.02; P=0.21). Bias analysis: results robust unless an unmeasured confounder were at least twice as prevalent with later treatment and raised odds of death by >1.35.
- Absolute risks
Bundle completion at 6 h vs within the first hour associated with approximately 3 percentage points higher in-hospital mortality (predicted, typical patient); crude in-hospital mortality 22.6% (bundle <=3 h) vs 23.6% (3-12 h)
- Authors' conclusion
Longer time to completion of the 3-hour bundle and to antibiotics was associated with higher risk-adjusted in-hospital mortality; time to fluid bolus was not; if causal, faster recognition and treatment could reduce avoidable deaths.
6. Strengths
- Large mandated statewide dataset with audits (>98% of audited cases confirmed sepsis)
- Pre-specified covariates and validated risk model
- Multiple sensitivity analyses and quantitative bias analysis
- Dose-response by hour
7. Weaknesses
- Not randomised; residual confounding (e.g. diagnostic difficulty delaying treatment)
- Appropriateness of antibiotic choice not known
- One US state; Sepsis-2 definitions
- Patients with bundle >12 h excluded; time-zero inaccuracies possible
- Per-hour effect small (4% odds increase)
8. Risk of bias
- Orienting tool
- ROBINS-I
- Type of assessment
- structured assessment based on the full text by a single reviewer (no formal double review)
- Full formal assessment
- no
- Overall risk of bias
- some concerns
- Rationale
Single-reviewer structured ROBINS-I-oriented judgement based on the full text ('some_concerns' corresponds to ROBINS-I 'moderate'); not formal (needs two independent reviewers and a protocol).
| Domain | Judgement | Rationale |
|---|---|---|
| Confounding | some concerns | Extensive risk adjustment and bias analysis, but atypical presentations may both delay treatment and raise mortality. |
| Selection of participants | some concerns | Restriction to ED protocols within 6 h and bundle within 12 h; excludes very delayed or hospital-onset cases. |
| Classification of interventions | some concerns | Time stamps from case-report forms; protocol start may not equal recognition time (sensitivity analysis from ED arrival similar). |
| Deviations from intended interventions | not applicable | Exposure is observed timing. |
| Missing data | low | Mandated reporting with audits. |
| Measurement of outcomes | low | In-hospital death objective; hospice reclassification did not change results. |
| Selection of reported result | low | Primary exposure and outcome pre-specified; sensitivity analyses reported. |
Full-text review (25 October 2026): Added inclusion/exclusion flow (111,816 to 49,331), median treatment times, overall mortality 22.8%, 3-12 h vs <=3 h ORs, absolute difference (~3 percentage points), bias analysis, funding; ROBINS-I domains (overall unchanged).
9. Assessment of the statistical interpretation
Small per-hour relative effects (OR 1.04) on a high baseline mortality (about 23%) translate into an estimated ~3 percentage-point higher mortality when bundle completion is delayed from 1 to 6 hours; association, not proven causation.
10. Relevance to the specific claim
Contradicts C-ABX-12.
11. Independent contrary findings
12. Transferability to Germany and Europe
High.
13. Overall methodological judgement
Strong observational evidence that delayed antibiotics in sepsis are associated with higher mortality; directly contradicts a blanket refusal of antibiotics in serious infection.
| Multidimensional assessment | |
|---|---|
| Authenticity of the source | verified |
| Methodological quality | high |
| Risk of bias | some concerns |
| Precision of results | high |
| Directness | direct |
| Reproducibility | replicated |
| Consistency with the overall evidence | consistent |
| Regional transferability | high |
| Adequacy of the interpretation (by the archive) | not applicable |
14. Open questions
15. Linked fact checks
- Antibiotics should not be used as a treatment at all; nobody should take an antibiotic for any reason (not even after a tooth extraction); the body can cope on its own. – Studies contradicting or limiting the claim